Singapore markets closed

Teladoc Health, Inc. (TDOC)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
15.10-0.17 (-1.11%)
At close: 04:00PM EDT
15.16 +0.06 (+0.40%)
After hours: 07:52PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.52B
Enterprise value 2.99B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.95
Price/book (mrq)1.08
Enterprise value/revenue 1.15
Enterprise value/EBITDA 19.42

Trading information

Stock price history

Beta (5Y monthly) 0.94
52-week change 3-41.70%
S&P500 52-week change 327.86%
52-week high 330.41
52-week low 314.29
50-day moving average 317.48
200-day moving average 320.31

Share statistics

Avg vol (3-month) 34.67M
Avg vol (10-day) 33.32M
Shares outstanding 5167.04M
Implied shares outstanding 6167.04M
Float 8165.53M
% held by insiders 10.79%
% held by institutions 175.85%
Shares short (15 Mar 2024) 420.28M
Short ratio (15 Mar 2024) 42.87
Short % of float (15 Mar 2024) 413.79%
Short % of shares outstanding (15 Mar 2024) 412.14%
Shares short (prior month 15 Feb 2024) 420.51M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -8.47%
Operating margin (ttm)-4.53%

Management effectiveness

Return on assets (ttm)-3.01%
Return on equity (ttm)-9.51%

Income statement

Revenue (ttm)2.6B
Revenue per share (ttm)15.81
Quarterly revenue growth (yoy)3.60%
Gross profit (ttm)N/A
EBITDA 46.22M
Net income avi to common (ttm)-220.37M
Diluted EPS (ttm)-1.34
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.12B
Total cash per share (mrq)6.73
Total debt (mrq)1.6B
Total debt/equity (mrq)68.62%
Current ratio (mrq)3.54
Book value per share (mrq)13.96

Cash flow statement

Operating cash flow (ttm)350.02M
Levered free cash flow (ttm)306M